1,698 results on '"Tang, W.H. Wilson"'
Search Results
102. Meta-Analysis Comparing Frequency of Overweight Versus Normal Weight in Patients With New-Onset Heart Failure
103. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease
104. Hemodynamic factors associated with serum chloride in ambulatory patients with advanced heart failure
105. Metabolic Biomarkers in Heart Failure
106. Targeted Inhibition of Gut Microbial TMAO Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease
107. L-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
108. Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients
109. Sodium and potassium changes during decongestion with acetazolamide – a pre‐specified analysis from the ADVOR trial
110. Gut Microbiome-Based Management of Patients With Heart Failure
111. Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives
112. Durable Mechanical Circulatory Support in Patients With Amyloid Cardiomyopathy: Insights From INTERMACS
113. Renal response to intravascular volume expansion in euvolemic heart failure patients with reduced ejection fraction: Mechanistic insights and clinical implications
114. Intrarenal Flow Alterations During Transition From Euvolemia to Intravascular Volume Expansion in Heart Failure Patients
115. An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial
116. Patients Not Meeting PARADIGM-HF Enrollment Criteria Are Eligible for Sacubitril/Valsartan on the Basis of FDA Approval: The Need to Close the Gap
117. Circulating intestinal fatty acid-binding protein (I-FABP) levels in acute decompensated heart failure
118. Relation of Red Cell Distribution Width to Left Ventricular End-Diastolic Pressure and Mortality in Patients With and Without Heart Failure
119. Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure
120. Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations
121. Microbiome, trimethylamine N-oxide, and cardiometabolic disease
122. Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF)
123. Impact of Iron Deficiency on Response to and Remodeling After Cardiac Resynchronization Therapy
124. Multiomics Insights to Accelerate Drug Development: Will They Hold Their Promises?
125. List of Contributors
126. Biomarkers to Assess and Guide the Management of Heart Failure
127. Sodium-Glucose Cotransporter-2 Inhibitors and Loop Diuretics for Heart Failure: Priming the Natriuretic and Metabolic Reserve of the Kidney
128. Virtual Versus In-Person Visits and Appointment No-Show Rates in Heart Failure Care Transitions
129. Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure
130. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease
131. Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF
132. A common variant alters SCN5A-miR-24 interaction and associates with heart failure mortality
133. Gut Microbiota–Derived Trimethylamine N-Oxide Contributes to Abdominal Aortic Aneurysm Through Inflammatory and Apoptotic Mechanisms
134. Prognostic Value Of Composite Biomarkers In ASCEND-HF Biomarker Registry
135. Impact Of Sarcopenic Obesity On Outcomes Following Acute Decompensated Heart Failure Hospitalization
136. External Validation Of Diuretic Efficiency Risk Prediction Tool
137. Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality
138. Using Integrated Electronic Health Record Data to Identify Clinical Trial-Based Opportunities for Guideline-Directed Medical Therapy Expansion
139. Hemodynamic Gain Index and Exercise Capacity in Heart Failure With Preserved Ejection Fraction
140. Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension
141. Fingerprinting MINOCA
142. Performance of a targeted methylation-based multi-cancer early detection test by race and ethnicity
143. Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases
144. Focal fibrosis and diffuse fibrosis are predictors of reversed left ventricular remodeling in patients with non-ischemic cardiomyopathy
145. Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial
146. Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure
147. Renal biomarkers and outcomes in outpatients with heart failure: The Atlanta cardiomyopathy consortium
148. Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass
149. Transient Hyponatremia During Hospitalization for Acute Heart Failure
150. The Impact of Donor and Recipient Renal Dysfunction on Cardiac Allograft Survival: Insights Into Reno-Cardiac Interactions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.